Average Co-Inventor Count = 4.39
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sigma-tau Industrie Farmaceutiche Riunite S.p.a. (31 from 343 patents)
2. Istituto Nazionale Per Lo Studio E La Cura Dei Tumori (4 from 14 patents)
3. Sigma-tau Research Switzerland S.a. (3 from 3 patents)
4. Biogem S.c. a R.l. (3 from 3 patents)
5. Instituto Nazionale Per Lo Studio E La Cura Dei Tumori (2 from 3 patents)
6. Sigma-tau Farmaceutiche Riunite, S.p.a. (1 from 3 patents)
7. Istituo Nazionale Per Lo Studio E La Cura Dei Tumori (1 from 1 patent)
8. Alfasigma S.p.a. (21 patents)
38 patents:
1. 11819484 - Retinoid derivatives with antitumor activity
2. 11364216 - Retinoid derivatives with antitumor activity
3. 10905668 - Retinoid derivatives with antitumor activity
4. 9302998 - Aryl triazole compounds with antitumoural activity
5. 9023861 - Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents
6. 8975248 - Combinations of therapeutic agents for treating cancer
7. 8927533 - Thio derivatives bearing lactams as potent HDAC inhibitors and their uses as medicaments
8. 8853233 - Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
9. 8829021 - Treatment of pediatric tumors
10. 8530517 - Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
11. 8383616 - Aryl isoxazole compounds with antitumoural activities
12. 8222231 - Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
13. 8101793 - Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
14. 8067555 - Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
15. 8053460 - Indole derivatives having antitumor activity